COVID-19 Toolkit
NOTE: Created on April 3, 2020, this resource has been added to the toolkit menu for retrospective access if needed.
The situation surrounding the COVID-19 pandemic will continue to change and evolve; what will not change is our Society’s commitment to do everything we can to support our members. ISOPP is therefore committed to collecting and sharing COVID-19 and Cancer Care resources.
We are delighted to share resources which provide COVID-19 guidance from various regulators to knowledge support to pharmacists and patients for cancer care during this pandemic. Through our resources, we provide further support to our membership with some of the most interesting research findings and virtual interactions with experts related to the impact of COVID-19 on cancer care globally.
We have divided these resources into 5 categories.
Date resource created: April 3, 2020
Resources
- World Health Organisation - Coronavirus disease (COVID-19) pandemic
- European Medicines Agency. Coronavirus disease (COVID-19)
- Centers for Disease Control and Prevention – Coronavirus (COVID-19)
- Australian Government, Department of Health - Coronavirus (COVID-19) resources for health professionals, including aged care providers, pathology providers and healthcare managers
- COVID-19 resources from National Comprehensive Cancer Network: Offers recommendations on the provision of cancer care for a range of different cancer sites and supportive care areas.
- American Society of Clinical Oncology (ASCO) Coronavirus Resources: Covers a wide range of topics, including modifications to patient care, service provision, resource allocation and occupational safety during the COVID-19 pandemic in an FAQ format.
- Emergency Resources: COVID-19 from Society of Critical Care Medicine: Comprises a rapid resource centre with FAQs relevant to the provision of patient care and services in critical care.
- Resources from American Society of Health-System Pharmacists: Provides a summary table on evidence related to COVID-19 treatments and updates on the current status of pharmacy supplies in the United States.
- Pharmacists’ guide to Corona Virus, American Pharmacist Association: Provides a summary page of practical information that pharmacists should know during the COVID-19 pandemic. Also contains links to CDC guidance documents and PubMed search results for the latest COVID-19 literature.
- National Institute for Health and Care Excellence (NICE): Summarizes rapid guidelines and evidence summaries on COVID-19 treatments and patient care (including cancer patients) during the pandemic.
- Clinical evidences summaries from Ministry of Health, Singapore: Consists of clinical evidence summaries by the Ministry of Health, Singapore on potential COVID-19 treatments.
- COVID-19 resources from CADTH: Offers a comprehensive COVID-19 evidence bundle that provides evidence summaries on COVID-19 prevention, infection control, screening/testing and treatment.
- The New England Journal of Medicine. Coronavirus (Covid-19)
- JAMA: The Journal of American Medical Association. Coronavirus Disease 2019 (COVID-19)
- Elsevier resource centre on COVID-19
- The Lancet. COVID-19 Resource Centre
- British Medical Journal. Coronavirus (Covid-19)
- Articles on CDC
- Articles on Oxford journals
- Articles from Nature
- Articles from Wiley online library
- Articles from Cambridge University press
- Cell Press Coronavirus Resource Hub
- Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal.
- Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
- Clinical guide for the management of non-coronavirus patients requiring acute treatment: Cancer.
- A War on Two Fronts: Cancer Care in the Time of COVID-19
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
- Managing COVID-19 in the oncology clinic and avoiding the distraction effect.
- Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective.
- Practical considerations for the management of cancer patients during the COVID19 pandemic, from e Medical Oncology Group of Australia. (draft version only)
- COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis
- Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety by ISOPP
- Webinar series from ASCO
- ASHP discussion forum
- Webinars from American Pharmacists Association
- OncoAlert Round Table The Italian COVID19 Experience
- OncoAlert Round Table Discussions: The Global COVID19 Experience
- Now: Briefing & Exchanges on China’s COVID-19 Experiences
- COVID-19 Webinar: Implications for Canadian Cancer Care by Canadian Association of Medical Oncologists and Oncology Education
- COVID-19: What Pharmacists Know Now
- An ISOPP webinar on Global Oncology Pharmacy Response to COVID-19 Pandemic
Would you like to share more resources on COVID-19 with ISOPP members? Send your resources to the Education Committee Chair at education@isopp.org.